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The toxicity of internally deposited radioactive metals (S8U probably 
being the Single exception) to the living organism is a result of the emitted 
ionizing radiations. Therefore this subject would qualify as a Special chapter 
of radiobiology. However, investigations utilizing internal emitters have 
contributed little to the elucidation of radiobiological problems. This is due 
to the fact that  temporal and spatial dose distributions produced by internal 
radiation cannot be controlled to the same extent as distributions can be 
with external radiation sources. Hence, the influence of several parameters, 
which are essential for a radiobiological analysis, can only be determined 
with difficulty. Correspondingly, the desire for ansnrers to practical problems 
rather than fundamental radiobiology initiated the very intensive and 
detailed studies on the toxicity of radionuclides during the last two decades. 
There is no need to Stress the immense practical importance of evaluating 
the potential hazard for man of radioriuclides, and the determination of their 
maximal permissible concentrations (MPC) in the human body, in water, 
and in the air. I t  does not seem practical to limit this review only to the 
toxicity of radiometals in the strict definition of this word; a deeper under- 
standing of the metabolic behavior of radiometals in general, which in turn 
depends on various factors, is a necessary prerequisite for other than a 
purely phenomenological treatise and especially for MPC calculations. 
The present survey is essentially restricted to the work published in 
1960 and 1961; for earlier work, reference is  made to the comprehensive 
reviews of Chen et al. (38), Foreman (54), and Thompson (152). A separa- 
tion into paragraphs dealing with individual radiometals is adopted. This, 
however, unavoidably leads to the impression of a casuistic and accidental 
treatment, due to the relatively short period of time covered. In order to 
counteract this tendency, general considerations and several relevant and 
generally valid questions are discussed a t  the outset making i t  possible to 
locate more specialized work within a wider frame. 
1 The survey of the literature pertaining to this review was concluded in March, 
1962. 
* Abbreviations used in this chapter include: BADE (2 :Y-bis-[di(carboxylmethyl) 
aminol-diethylether); DF (discrimination factor); DTPA (diethylenetriaminepenta- 
acetic acid); *ICRP (International Committee of Radiological Protection); LET 
(linear energy transfer); MPC (maximal permissible concentrations); OR (observed 
ratio); TTHA (triethylenetetraaminehexaacetic acid); *EDTA (ethylenediamine- 
tetraacetic acid. 
CATSCH 
Screening investigations on distribution and excretion patterns of radio- 
metals can be regarded as  completed now t h a t  the rarer and (from a practical 
viewpoint) less important elements have been included. In summarizing this 
work i t  would seem tempting to classify radiometals by their metabolic 
behavior as  related to their chemical qualities, and their place in the  peri- 
odical system. Such analyses [e.g., Durbin (45)] reveal only a limited correla- 
tion. Although the far-reaching analogies between the metabolism of elements 
in  certain main groups (e.g., alkaline metals, alkaline earths o r  lanthanides) 
are  very well known, these, however, are  not  found for elements of other 
groups or subgroups. In view of the relatively numerous exceptions, a tenta- 
tive a t t empt  to  correlate the metabolic behavior of radiometals to  their 
valency does not appear convincing. 
T h e  behavior of a given radiometal in the organism can ultimately be 
explained by  certain chemical, particularly coordination-chemical, and ion 
exchange processes. Attempts to  specify these purely general and formal 
considerations have progressed only slowly, and many results are  not  ye t  
free of ambiguities and contradictions. T h e  causes are  primarily methodical 
ones: The  classical procedures of separation and  purification of defined bio- 
chemical fractions from tissues and body fluids usually entail drastic changes 
of pH, or make use of substances with coordination tendencies or adsorbing 
qualities. Hence, the preservation of the original biochemical distribution 
pattern is not assured. Especially with carrier-free radionuclides possessing 
a stronger tendency to form radiocolloids, the danger of artifacts arises. 
Further, the value of in vitro investigations of relatively simple models 
ought not to be overestimated. The  difficulties of transferring the  obtained 
results to  the complex biological milieu, for which a multitude of competing 
reaction partners is characteristic, are  self-evident. 
Returning to the problem of metabolism of chemically related elements, 
present interest is concentrated on elaborating finer quantitative differences 
in the behavior of element-pairs (e.g., Sr-Ca or Cs-K) and on investiga- 
tions of the mechanisms which are  responsible for biological discrimination. 
A Summary of the present situation in respect to  these questions and defini- 
tion of the nomenclature used is given by Comar 6r Wasserman (41). These 
authors stress the practical importance of the so-called OR (observed ratio) 
of the pair Sr- Ca for the assessment of the radiation hazard and prediction 
of the radio-contaminant level in the human population. The  OR is defined 
a s  
Sr/Ca in sample 
ORnamp~e-precursor = Sr/Ca in precursor 
T h e  term discrimination factor (DF)  applies t o  a particular physiological 
process which is responsible for the differential behavior of a n  element-pair, 
and is linked to the O R  by  
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The  conditions for a valid application of DF- and OR-values are  discussed 
in a general way by  Kornberg (74); theoretical a s  well a s  experimental evi- 
dence indicates t h a t  variations of discrimination may occur. This  applies 
to  Cs- K even more than to Sr-Ca. Summarizing, Kornberg recommends 
t h a t  90Sr contamination be reported in terms of ratios a s  well a s  absolute 
concentration units. 
An exact mathematical formulation of retention and excretion of a 
radionuclide in long-term experiments is of great  practical importance in so 
far  a s  i t  is requisite for the calculation of h l P C  values. Furthermore, such a 
formulation admits the possibility of estimating the body burden from 
measured excretion rates and, under certain conditions, the time of incorpora- 
tion of the  radionuclide. Direct observations on man must be preferred t o  
experiments with animals, a consequence of the greatly different behavior of 
certain radiometals in different species and the resulting uncertainty in the 
extrapolation of animal d a t a  t o  man. The  retention and excretion functions 
are  generally given in a multiple exponential formulation because simple 
exponential functions are  only very rarely sufficient: 
o r  approximated a s  power law: 
where Rt is the amount  of radiometal retained after t days, E$ the excretion 
rate  a t  day  t, while ai, bi, c and d are constants; ai and C are  usually given 
a s  percentage of the dose administered. KThile a power function doubtlessly 
has the advantage of simplicity, i t  has only formal meaning. A multiple 
exponential formulation is preferable, however, because i t  affords the pos- 
sibility of correlating real physiological compartments o r  processes xvith the 
mathematical terms of the  function, thus attaching biological significance 
t o  them. 
Early Screening tests concerned with the metabolism of radiometals were 
usually restricted t o  a single administration of the nuclide. During the last 
few years, however, interest has shifted to  experimental arrangements in 
which the radiometal is given continuously and i ts  build-up in different 
Organs is observed. This  procedure has made possible evaluations of h l P C  
values which naturally are  more reliable than d a t a  based on a single admin- 
istration of the radionuclide. Investigations of this type may also entail 
more o r  less drastic future revisions of the present recommendations of the 
I C R P  (International Committee of Radiological Protection). 
From the  practical point of view, and taking into consideration all past 
experiences, the ingestion and inhalation of radiometals are  the main routes 
for their entry into the body. T h a t  our knolvledge about  the fate of inhaled 
radiometals is scanty, especially quantitatively, is partly caused by the  
difficulties of experimental techniques, and partly because the multitude of 
physical, chemical, and physiological factors which can influence the deposi- 
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tion and  retention of inhaled particles. Concerning the  physical parameters 
other than their density, which determine the  extent of deposition the size 
of the  particles plays a decisive role according to Morrow (101). T h e  dominat- 
ing influence on particles of diameter more than 0 .5p is  gravitational settling; 
for particles of less than 0.1 p diameter, impacts from Brownian motion 
dominate; whereas, in the intermediate range of 0.1-0.5 p stable aerosols 
are  formed and a relatively small percentage are  subject t o  deposition in the  
respiratory tract. Modifying factors (i.e., coagulation of submicroscopic 
particles, their role a s  condensation centers, and thermal effects) add to the 
difficulties which have to be dealt with before the extent  of deposition can 
be quantitatively predicted or mathematically formulated. This  is addi- 
tionally complicated by the fact t h a t  the number of deposited particles 
depends upon purely physiological factors, such a s  tidal volume and  respira- 
tory frequency. Those factors which are  responsible for the further fate of 
the deposited aerosols and also for elimination mechanisms (e.g., lung 
clearance due to the activity of ciliated epithelial cells, phagocytosis, 
lymphatic drainage, a s  well a s  final solubilization and subsequent absorption 
of particles) are  discussed by Casarett  (22). T h e  experimental deposition 
data ,  as  given in a review of investigations with different aerosols [Bair (3)] 
are  in good agreement with theoretical expectations; namely, t h a t  the frac- 
tion of material deposited after inhalation is largest with particles of approxi- 
mately 2 p diameter and smallest a t  0.3 p. According to Bair (3) the experi- 
mental d a t a  d o  lend some credence t o  the  basic assumptions of the I C R P  
recommendations. T h a t  is, in  the Standard man 75 per cent  of the dus t  
he breathes will be deposited in  the whole respiratory t ract  and  approx- 
mately one third in its lower parts. T h e  retention is usually represented by  a 
sum of several exponential terms with half-times of a few days through 
several hundred days. This  signifies, a t  least in  principle, the action of 
different clearance mechanisms. T h e  preponderance of one or  another par- 
ticular mechanism depends of Course on the kind and chemical composition 
of the inhaled particles. I t  should be mentioned, however, t h a t  the observed 
retention is not  necessarily related to  the  properties of the compounds in  
pure solutions. Thus, inhaled Ag1 is rapidly absorbed from the  lungs, al- 
though i t  is only weakly soluble in  water [Willard & Bair (169)l. Also, 
Bair (3) in agreement with Stannard (146) points ou t  the  accumulation of 
inhaled insoluble radiometals in tracheobronchial lymph nodes, a fact which 
may gain importance for evaluations of the MPC. However, considerably 
more information about  the pathological consequences of a localized lym- 
phatic deposition will be needed to assess i t s  importance. An unexpected 
observation of possibly more general significance was made by Cember et al. 
(37) in experiments with mice to  which Ba35O4 and Ba35SOr had been 
given. An interaction between radiation level and lung burden seemed t o  
exist insofar a s  the lung clearance was decelerated with application of lower 
specific activity, i.e., higher lung burden. This could mean t h a t  the  lung 
hazard is  a n  inverse function of the specific activity of the inhaled aerosol. 
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Whereas formerly, often tacitly, the assumption was made that  the 
metabolic behavior of internally deposited radiometals is independent of 
the radioactivity level over a wide range, more recent investigations have 
shown that  this is not necessarily true. Especially in the skeleton, deposition 
of toxic amounts of radioactivity seem to impair elimination processes. 
Investigations pursuing the influence of external radiation on the metabolism 
of internal emitters are bearing upon these questions and are not without 
practical importance; for example, a nuclear disaster resulting in simul- 
taneous exposure to external and internal irradiation. 
To date, the acute LD60 has been determined for most of the practically 
important radiometals, and the qualitative aspects of radiotoxicity have 
been treated rather exhaustively. Henceforth, we should find the "center of 
gravity" of toxicological studies shifting toward investigations in which the 
practically encountered types of incorporation (like continuous ingestion or 
inhalation) occur, as well as the quantitative elucidation of long-term effects. 
Of special interest-also in regard to MPC evaluations-is the question of 
dose relationship and of a threshold dose. Probably the most comprehen- 
sive experimental material bearing on this question is due to Finkel (49), 
who investigated the incidence of lymphatic tumors and osteosarcomas after 
injection of mice with single doses of 90Sr. The essential result can be sum- 
marized as follows: a plot of the response versus the dose injected (pc/g) 
does not show a linear relationship, and indicates that  the existence of a 
threshold dose is quite possible. I t  is thought that  doses below this threshold 
do not produce tumors, which is in accord with more general theoretical 
considerations about carcinogenesis by Brues (17). The impossibility of ob- 
taining more precise conclusions can be explained statistically. Another 
difficulty in interpretation Comes from the fact that  the radiation doses 
accumulated depend not only on the amount of the activity administered 
but, also, on the lifetime of the experimental animals. The lifetime of the 
animals depends in turn on the amount of the radiometal given. Archer & 
Carroll (2) proposed to allow for this by plotting the response against the 
pc-days/g amounts of activity. However, as was pointed out  by Finkel (SO), 
this is an oversimplification of the problem insofar as i t  equates the radia- 
tion dose accumulated during the lifetime to the, actual radiation dose for 
the induction of a tumor (or any other disease); of Course, this cannot be the 
case. Even if in favorable cases i t  should be possible toseparatemorbidity from 
mortality (i.e., true incidence of disease from its apparent incidence a t  
death), i t  still would be very difficult, if a t  all possible, to determine exactly 
the duration of the real time of latency and the amount of "wasted" radia- 
tion. Further complications of this problem arise from the fact that  in the 
higher dose region the frequency of tumors decreases despite increasing 
doses. This means that  a t  high doses the cell killing effectiveness of the radia- 
tion dominates. Since the dose rate may constitute a decisive factor in the 
induction of radiation damage, a final complication is introduced by the fact 
that  the dose rate usually decreases because of the radioactive decay, or the 
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excretion of an internal emitter or both. For this Same reason i t  is not possible 
to predict the consequences of chronic exposure from single dose data;  
actual e~~er imen ta t ion  is needed. This is even more so since chronic exposure, 
compared to the administration of a single dose, not only results in a different 
temporal dose distribution but also in a more uniform spatial distribution of 
radiation doses. For small animals, whose organs are smaller than the mean 
range of the emitted radiation, this factor may be neglected; not, however, 
for larger species and man. For this reason alone experiments with animals 
larger than small rodents would be required. A series of experiments with 
dogs have been initiated, but clear-cut results are yet to be obtained. I t  
remains to mention that  the temporal distribution of the radiation dose 
seems to have different importance for radiations with different LET; as 
was pointed out by Moskalev (102) on review of experimental data with 
various radionuclides, the recovery processes are less efficient after a irra- 
diation compared to ß and y irradiation 
A quantitative analysis of radiotoxicity requires a determination of the 
radiation doses which accumulates in the organs after administration of a 
given amount of radionuclides. For this, knowledge of the retention functions 
as well as the microscopic distribution in the organ under scrutiny is needed, 
as dose calculations on the basis of average organ concentrations lead only 
very rarely to realistic estimates. This applies primarily to deposition in the 
lungs after inhalation exposure as well as to distribution Patterns of most 
radiometals in the Skeleton, which in autoradiographs show a pronounced 
nonuniform and spotty deposition. The nonuniformity-factor will in such 
calculations be more important the smaller the range of the emitted particles, 
that is with soft ß or <r emitters. A detailed mathematical treatment of dose 
calculations is given by Björnerstedt & Engström (14), with Special considera- 
tion of the inhomogenous distribution, to the critically interesting case of 
deposition in bone. A different and very promising approach, which is 
attributed to Hoecker & Roofe (64) and Spiers (142) and has the advantage 
of directness, was recently taken up by Hindmarsh et al. (63) and Rowland 
& hlarshall (128). I t  is based on the counting of <r tracks in autoradiographs 
or the photometry of blackening in thick section autoradiographs. Another 
direct dosimetric method is the use of Schulman-Etzel dosimeters consisting 
of small-volume silver phosphate glass for direct measurments of the radia- 
tion dose delivered to the organs. This method is discussed in detail by 
Hayes et al. (61). I t  appears questionable, however, whether dose measure- 
ments by implantation of such dosimeters can gain wider importance, 
apart from certain problems such as the irradiation burden of the intestinal 
tract after ingestion of a nonabsorbable radionuclide [Nold et al. (107)l. I t  
is obvious that computations or measurements of radiation doses lead to  
considerably higher values, if the spotty distribution of radioactivity is 
taken into account, than under assumption of a uniform distribution. How- 
ever, the influence of nonuniformity of the dose distribution in regard to the 
pathological sequelae has not finally been cleared up. In other words, i t  is 
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still arguable whether a defined portion of the bone (or another organ) 
rather than the total bone has to be regarded as the critical organ. 
A treatise of radiotoxicity would be incomplete if possibilities of thera- 
peutic treatment were not mentioned. Effective measures can in the present 
state of our knowledge only consist in attempts to prohibit or reverse those 
chemical reactions which are responsible for the deposition of a radiometal. 
Of the numerous basic possibilities of achieving an intensification of excre- 
tion (chelating agents, isotopic dilution, and action on physiological func- 
tions) the use of chelators still appears to be the most promising. The 
physiochemical foundations and the factors which are relevant for the effec- 
tiveness of a chelating agent have already been discussed in detail by Schu- 
bert (133), and recently in a revised and more general form by Heller & 
Catsch (62). A survey of recent experimental results has been given by 
Catsch (26). Whereas until recently EDTA (ethylenediaminetetraacetic 
acid) was practically the only compound for which experimental data and 
clinical experiences were available, interest during the last few years has 
been concentrated on the considerably more efficient DTPA (diethylenetri- 
aminepentaacetic acid) and other related synthetic polyaminopolycarboxylic 
acids. The reason for the superiority of DTPA is to be found in the fact 
that  the ratio of the chelate stability constant for the meta1 ion tobe  removed 
to that  for calcium (the essential endogenous competing cation) reaches 
higher values than for EDTA. The stability of the Ca-chelates is principally 
greater than for the Sr-chelates in all chelators investigated so far, and there- 
fore their effectiveness for Sr removal is only minimal even under optimal 
conditions. Hence, the most promising approach in this case is probably a 
combination of measures or pharmaceuticals with different modes of action. 
One possible way of improving the effectiveness of chelating agents in 
delayed treatment, which is generally less efficient than early treatment, is 
opened up by pilot experiments with esterified polyamino acids [Catsch 
(25, 26)]. I t  is thought that  the higher effect of the esters is brought about 
by their ability to permeate cellular membranes. 
Transuranic elements.-The metabolic behavior of 241Am in rats shows 
a close similarity to that  of 239P~ ,  but also certain differences [Taylor et al. 
(150)J: faster removal of 24lAm from the liver and reduced initial deposition 
in the Skeleton. The retention of both of these radionuclides by the femur ob- 
served over a period of 600 days can be represented by simple exponential 
functions which read for Z4lArn: Rt=1.9 exp (-0.00043t) and for 23gPu: 
Rt =2.8 exp (-0.0005Zt). The fecal/urinary excretion ratio of 241Am and 
2 3 9 P ~  is smaller than unity only on the first day, but later reaches values be- 
tween six and nine. At the site of highest 241Am deposition in the femur, 
namely the "active band" of the metaphysis, the dose rates (as determined 
by an autoradiographic technique) on the second day after administration of 
0.0033 pc/g are a minimum of 21 rads per day, a maximum of 362 rads per 
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day, and on the average 138 rads per day. If the pronounced nonuniformity 
of the microscopic distribution is not taken into account in calculating the 
dosage, one obtains the completely unrealistic figure of 6.1 rads per day. In 
comparison to the results of Taylor et al. (150) a considerably faster removal 
of 239P~ from the skeleton was observed by Buldakov & Moskalev (19): 
Rt 150.6 exp (-0.0013t). While fractionated administration of 239Pu does not 
influence its skeletal retention, a clear but inexplicable difference is found in 
the liver: Rt =4.36 exp (-0.0036t) for a single dose and Rt =3.34 exp 
(-0.0144t)+0.66 or Rt=3.3t.U respectively for a fractionated dose. The 
investigations by Rysina (130) into the behavior of 239P~ in dogs are not 
evaluable quantitatively. By and large, however, they confirm the pre- 
viously found slower clearance from the liver in comparison to small ro- 
dents. About 20 per Cent of an inhaled n9PuO2 aerosol with a mean particle 
size of 0.2 p was retained by the lungs of mice [Bair et al. (6)].  The clearance 
from the lungs correspond to Rt = 70 exp (-0.23t) +25 exp (-0.034t)+4 exp 
(-0.0015t). The largest quantity of translocated 239P~ was accumulated in 
the skeleton, about 0.3 per cent of the total dose. Assuming a uniform dis- 
tribution of 2 3 9 P ~  in the lungs-which actually is not the case-the accumu- 
lated radiation dose is computed as 550 rads in 70 days after deposition of 
0.02 pc. Using these experimental data the MPC for man is computed as 
1.6'10-l0 pc/cc air compared to the value of 4'10-" pc/cc recommended by 
the ICRP. After exposure of two dogs to a 2 3 9 P ~ 0 2  aerosol with a geometric 
mean particle size of 0.6 p, 75 per cent of the inhaled aerosol was found in the 
lungs and 20 per Cent thereof in the upper respiratory tract IBair et al. (4)]. 
The daily excretion can be described by a power law where-a characteristic 
of inhalation exposure-the fecal excretion is about two orders of magnitude 
higher than the urinary excretion. The whole body retention is represented 
by Rt=47 exp (-0.12t)+4 exp (-0.028t)+49 exp (-0.00048t) and Rt=25 
exp (-0.23t)+8 exp (-0.046t)f 67 exp (-0.00039t) respectively. I t  is im- 
portant that  a t  later times the W9Pu concentrations in the lungs are lower 
than those in the bronchial and mediastinal lymph nodes. The question of 
the critical Organ cannot be answered yet, as on one hand the pathological 
sequelae of the lymphatic drainage are not known; and on the other hand, the 
comparison with the average concentration in the lungs may be misleading in 
that  i t  does not allow for the localization of "9Pu in "hot spots." Tissue analy- 
sis from a 239Pu-process operator whose death resulted from an overdose of 
external radiation, and who had been exposed to 239Pu for approximately six 
years via inhalation, was performed by Foreman et al. (56). A total body 
burden of about 0.018 pc was estimated. I t  is noteworthy that  the 2 3 9 P ~  con- 
centrations of the pulmonary lymph nodes exceeded markedly those of the 
other Organs. 
Concerning the kind and site of 239Pu binding in bone, according to 
Tseveleva (156) about 90 per Cent can be found in the organic fraction ex- 
tracted by trichloracetic acid and the bulk of this in the collagen. This result 
is not convincing, however, for those reasons discussed earlier, and is in con- 
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tradiction to the affinity of 2 3 9 P ~  to the bone mineral which was found by 
Foreman (55). A determination by Twente & Jee (157) of the 2 3 9 P ~  concen- 
tration in the bone using a microdensitometric technique showed satisfactory 
agreement with the usual method of counting a tracks. On a beagle injected 
with 2.85 pc/kg, endosteal surface deposits of 1.6.10-6ppc per p2 were found 
after 92 days and the corresponding dose rates delivered to bone tissue and 
marrow cells were 40-60 rads/day. The autoradiographic distribution of 
239Pu in the Skeleton was investigated very thoroughly by Jee & Arnold (69) 
and related to radiographic and histopathological changes in early and de- 
layed Stages of poisoning. I t  was found that  bone lesions can be of direct as 
well as of an indirect nature. Certain changes like the death of osteocytes 
and the plugging of Haversian canals can be explained by a disrupted blood 
supply [Jee & Arnold (67)]. The impairment of bone function is also revealed 
by a reduced uptake of 32P, 'Ta ,  and "C-labelled glycine into the epiphysis of 
the rat  femur [Yelkina & Tseveleva (170)l. Jee & Arnold (68) further in- 
vestigated the hitherto neglected microscopic distribution of 239Pu and the 
induced pathological changes in jaws and teeth; osteogenic sarcomas oc- 
curred in the jaws but not in the dental tissue. The marked retention of 
239Pu by the liver of dogs manifests itself not only in morphological changes 
but also in functional changes, as for instance the production of bile [Fedor- 
ovsky (48)l. 
Concerning the dependence of 2 3 9 P ~  toxicity upon the dose rate, hloskalev 
et al. (104) report that  single doses are significantly more effective than frac- 
tionated ones in the induction of hematological reactions, and the reduction 
of life-span of rats. The induction of osteosarcomas, however, does not appear 
to be affected by these two different kinds of application, in contrast to ß 
emitters like 90Sr or 144Ce. 
* 3 9 P ~  administered orally is well known to be absorbed only slightly, and 
hence the intestinal tract is thought to be the critical Organ in this case. How- 
ever, investigations by Sullivan et al. (149) showed that  following oral ad- 
ministration of 2 3 9 P ~ 0 2  to rats, even after doses as high as  230 pc/g and be- 
cause of insufficient penetration of the a particles, only superficial epithelial 
damage occurred, and conspicuous toxicity or mortality were absent. Hence, 
the gastrointestinal tract in this case seems to be of secondary importance for 
determinations of the MPC. The histopathological changes in the respiratory 
tract of mice after intratracheal administration of 2 3 9 P ~ 0 2  were studied by 
Temple et al. (151). An increased frequency of papillary adenomas was ob- 
served only in animals having received 0.1 pc but not after smaller or higher 
doses. This result is compatible with the well-known fact that  after excessive 
amounts of radiation, cell killing surpasses carcinogenesis. 239Pu deposition 
was considered responsible for the deveiopment of 3 malignant pulmonary 
tumors a t  100 and 400 days after exposure when the calculated radiation dose 
was 2300 and 4000 rads respectively. 
The high effectiveness of DTPA could be confirmed for 2"Am removal 
from rats [Sowby & Taylor (139)]. Investigations in comparison to early ad- 
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ministration of DTPA show mobilization of smaller quantities of *S9Pu if the 
chelator is administered after a delay; delayed administration is still suffi- 
cient, however, from a therapeutic point of view [Smith et al. (138)l. I t  is 
pointed out  that  DTPA not only increases urinary but  also fecal excretion, 
and that  the effectiveness of DTPAremains obseravable for several days after 
cessation of treatment. This is in accord with an in vitro study by Linden- 
baum & Schubert (91) who found an increased amount of "9Pu in ultrafil- 
trates of tissue homogenates several days after administration of DTPA. 
According to Smith et al. (138) these experimental findings show that  a cer- 
tain amount of DTPA does penetrate the membrane of liver cells, and that  
the sustained action is due to the intracellular DTPA concentration-a pos- 
sibility discussed earlier by Catsch et al. (24, 26, 29) in analyses of their re- 
sults with I4'Ce. The effectiveness of DTPA is markedly reduced for 239P~ 
administered in a colloidal form compared to monorneric 239Pu [Schubert et 
al. (134)]. Belayev (10) investigated the effectiveness of 1,2-diarninocyclo- 
hexanetetraacetic acid in rats which seems to be comparable to the effective- 
ness of EDTA, i.e. considerably lower than that  of DTPA. The efficiencies of 
EDTA and DTPA were compared by Norwood (108) in 6 persons which had 
been contaminated by exposure to 2 3 9 P ~  over a period of three to eight 
years. EDTA intensified the urinary 2 3 9 P ~  excretion by a factor of approxi- 
mately 10, DTPA by a factor of 40 to 100. However the fecal excretion 
(which was not investigated systematically) was also increased by DTPA. 
This, in connection with the observations on experimental animals mentioned 
above, demonstrates that  determination of urinary excretion only leads to an 
underestimation of the DTPA effectiveness. In the case of a 239Pu deposition 
which was thoroughly investigated by Sanders (132), EDTA nras practically 
ineffective. Orally administered "9Pu is absorbed in very small fractions; in 
spite of this, an attempt to impede its absorption should be made in view of 
the high toxicity of 2 3 9 P ~ .  Cation-exchange resins have been shown to be 
effective in this respect, but only if administered shortly after the entry of 
"$Pu [Belayev (11)). 
Thoriunz.-Stover et al. (147) studied the metabolic behavior of intra- 
venously injected carrier-free 228Th-citrate in beagles. The plasma concentra- 
tion was found to drop rather quickly. The excretion was measured through 
1300 days. Initially the urinary excretion is much higher than the fecal, but  
after several years the two are about equal. The total daily excretion can be 
represented by 
About 80 per Cent of 228Th is retained by the skeleton, the remainder by the 
soft tissues, particularly the liver from which i t  is eliminated faster than 
from the bone. Estimated from soft tissue and skeletal data, the retention can 
be represented by Rt=18 exp (-0.0010t)+69 exp (-0.00014t). An essen- 
tially equal distribution pattern is found for 234Th in rats, while an isotopic 
dilution leads to the formation of colloidal aggregates in the blood and to a 
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pronounced deposition in liver and spleen [Catsch & Tocchini-Valentini 
(36), Fried & Schubert (57)]. The microscopic distribution of 228Th in dental 
tissues as well as its effect upon blood vessels of cortical bone is comparable to 
that  of 2 3 9 P ~  [Jee & Arnold (67-69)]. Catsch & Tocchini-Valentini (36) found 
an increased removal of 234Th by DTPA compared to EDTA, while the 10- 
dentate triethylenetetraaminehexaacetic acid was even more effective. As all 
chelating agests investigated so far show a very strong reduction of their 
effectiveness on isotopic dilution of 23'Th [Catsch & Tocchini-Valentini (36), 
Fried & Schubert (57)], hopes for their effectiveness on old deposits of 
thorotrast (ThO2) must be regarded as very low even under optimal condi- 
tions. 
In recent years repeated reports about late damage after diagnostical ad- 
ministration of thorotrast have appeared. A new case has recently been com- 
municated by Baserga et al. (9) : This was a bile duct carcinoma of the liver 
which appeared 14 years after injection of thorotrast into a cavity of a liver 
abscess. Thorotrast deposits were found on autopsy in liver, spleen, lymph 
nodes, bone marrow, and, to a lesser extent, in the testes. The latter ob- 
servation deserves to be noted insofar as some deposition of thorotrast in 
ovaries was also demonstrated in animals by Matthes & Kriege1 (98). Hence, 
the possibility of genetic damage should a t  least be considered. Baserga et al. 
(9) give an extensive bibliography and a compilation of 36 known cases of 
malignancy in man following administration of thorotrast. The fact of the 
carcinogenic action of thorotrast, and its relation to the radioactivity of 
a2Th and decay products thereof can hardly be doubted. The incidence of 
damages, however, is  difficult to estimate from casuistic observations. An in- 
creased value must, therefore, be attributed to investigations of nonselected 
groups of persons. The status of 35 patients with a mean retention time of 
thorotrast of about 15 years has been determined by Looney (94). Disregard- 
ing the occurrence of one or possibly two rare hepatic tumors of mesodermal 
origin, there were relatively few deleterious effects directly attributable to 
thorotrast administration in these patients. In order to evaluate the real fre- 
quencies of thorotrast induced damage, coordinated follow-up studies on a 
broad scale are needed. 
Poloniun~.-2~oPo has been the subject of intensive research during the 
last decade; among other radionuclides, the toxicology of 210Po is one of the 
most thoroughly investigated. The more recent publications on 210Po are 
concerned with very specialized aspects. In summarizing these experimental 
findings, i t  must be noted that  i t  is yet questionable whether the disturb- 
ances observed in 210Po poisoned animals-hypoxemic states [Bezin (12)], 
electrocardiographic changes [Moroz & Grozdov (100)], alterations of the 
kidney function [Poluboyarinova (117)], and of the cortical activity of supra- 
renals [Chuchukalo (40)l-are really pathogenically relevant Symptoms and 
not unspecific responses of secondary importance. Hematological and histo- 
pathological investigations by Mikhailovich & Erleksova (99) and Petrovich 
(116) yielded no new insights. Corresponding to the strong affinity of 210Po 
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for kidneys, the reduction of SH-groups (which can also be demonstrated in 
other organs) is most pronounced in the lcidneys [Zotova (17)]. Histological 
changes of the nervous system in the chronic state of poisoning are mainly in 
the sympathic extramural ganglia, as  observed by Lebedev (81). Within the 
last few years intensification of 2 1 0 P ~  excretion by chelating agents possessing 
SH-groups has been demonstrated. In addition to a marked fecal excretion of 
ZlOPo, a prolongation of the mean survival time after administration of sodium 
diethyldithiocarbamate has 11ow been observed by Krivchenkova (79). 
Rare Earths artd Yttrium-Retention and excretion of carrier-free 14'Ce 
in rats over a period of 60 days was studied by Slouka (136). The diminution 
of 144Ce content in blood can be represented by a sum of 3 exponential terms. 
The coefficients of these exponentials are in good agreement with ones de- 
rived earlier by Catsch et al. (31). The retention in liver and kidneys is rep- 
resented by simple exponential functions Rt=53.3 exp (-0.13t) and Rc=2.4 
e x p  (-0.067t) respectively, while the 14Te content of the skeleton remains 
nearly constant. The retention in the whole body has an effective half-time of 
about 142 days. The fecal excretion is 10 times higher on the average than the 
urinary excretion. According to Catsch (24), the retention by the liver of rats 
follo~vs an exponential law with a half-time of 7 days only up to the 30th day; 
thereafter the excretion rate drops markedly. In explanation of this a t  least 
2 liver compartments, responding in parallel toward chelating agents, are 
assumed. The distribution of carrier-free "'Ce in rats shows a marked de- 
pendence on Sex. I n  male rats, as compared to  females, a lower deposition is 
observed in the liver and higher concentrations in the kidneys and skeleton 
[Catsch (24, 25)]. The subcellular distribution of "'Ce was studied by Catsch 
et al. (29). Disregarding the first days after administration, the distribution of 
144Ce among the intracellular fractions (cytoplasm > mitochondria > micro- 
somes >nuclei) remains essentially constant. The  decrease in absorption of 
intraperitoneally applied Ia4Ce with increasing pH of the injected solution, or 
after isotopic dilution with CeC13, is explained by the formation of radiocol- 
loids or colloidal aggregates which are absorbed poorly [Spode & Gensicke 
(145)]. Isotopic dilution of QIY also results in a change of the distribution pat- 
tern, especially in a marked deposition in the reticuloendothelial organs 
[Gensicke & Spode (5911. The metabolic behavior of I53Sm is generally equal 
to that  of the lighter lanthanides [Spode & Gensicke (144)J. The placental 
transfer of 144Ce and 91Y is considerably lower than tha t  of OOSr and 13iCs 
[Kriegel et al. (75, 77, 78, 79)J. 
After inhalation exposure of rats to an aerosol of '"CeC13 with a mean par- 
ticle size of 1 p, approximately 10 per cent of the amount initially deposited 
in the lungs was absorbed [Buldakov et al. (20)]. In the Course of investiga- 
tions on the deposition of fall-out fission products in human lungs, "'Ce con- 
centrations in pulmonary lymph nodes were found to exceed the concentra- 
tion in the lungs by one to two orders of magnitude [Liebscher et al. (87)l. 
Numerous experimental data on the biological behavior of radioyttrium have 
been reviewed by Ramsden (119). Of special interest are investigations into 
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the affinity of 90+91Y for chemically defined body constituents. Regarding the 
s ta te  of Y in the blood, numerous experiments utilizing paper electrophoresis 
are  found to yield rather contradictory results. I t  is generally agreed, how- 
ever, t h a t  a variable fraction of the radionuclide applied to the paper remains 
immobile on the spot of application. Apart  from this, binding of Y by y and 
p globulins, and by  phospholipids as  well a s  low molecular weight plasma 
constituents is claimed to have been found. In  all likelihood the immobile 
fraction is formed by  binding of Y to cellulose. Hence the affinities mentioned 
could be considered partially a s  artifacts. Other methods, such a s  pressure 
filtration, equilibrium dialysis [Rosoff (126)j and especially density gradient 
electrophoresis [Ekman et al. (46)] established a pronounced affinity of 91Y 
a s  well a s  of 144Ce, l47Prn, and 16Ql'b to albumins, while binding by globulins 
was not confirmed. 
Razumovsky & Torchinskaya's (120) discovery of 144Ce deposition in the 
collagen fraction of bone appears questionable for methodological reasons 
and is in contradiction with reports by Jowsey et al. (70). The  latter authors 
showed by in vitro and autoradiographic investigations t h a t  deposition of OIY 
and radioactive lanthanides occur mainly in the bone mineral, a localization 
on highly mineralized quiescent or resorbing bone surfaces being character- 
istic. According to Neuman et al. (106), the preferential deposition of ¶lY 
on resorption cavities is due to  a n  elevated concentration of hydrogen and 
citrate ions. These ions are produced locally by  the osteoclasts. 
T h e  superior effectiveness of 2:2'-bis-[di(carboxymethyl)amino]-di- 
ethylether (BADE) and particularly D T P A  (compared to EDTA)  in re- 
moving internally deposited 14Ke and 9lY observed by  Catsch et al. (24, 26, 
31, 32) was confirmed by  Razumovsky et al. (120, 121, 122), Tregubenko et 
al. (155). In  addition, the first authors were able t o  show for in vivo and in 
vitro conditions a n  almost equal effectiveness of D T P A  and B A D E  on the 
slreleton in delayed treatment in  contrast to  early administration. The  de- 
pendence of D T P A  effectiveness on time and mode of administration was 
thoroughly investigated by Catsch (24). The  most important result is t h a t  
only a few doses of D T P A  are sufficient to  remove t h a t  fraction of 14'Ce from 
the body which is subject to  mobilization. In view of the relatively frequent 
contamination of wounds, the observation of DTPA-accelerated absorption 
of ld4Ce from intramuscular depots is of practical importance [Catsch 8: 
Kiefer (30)]. Catsch & Schindewolf-Jordan (34,35) tested the effectiveness of 
several new chelating agents. With the exception of triethylenetetraamine- 
hexaacetic acid (TTHA) all of them proved to be inferior to  DTPA. T T H A  
showed, if administered early, a significantly higher skeletal effectiveness 
than D T P A  with 144Ce and 91Y. 
T h e  amount  of QIY absorbed in the intestinal t ract  does not  exceed 0.05 
per cent. T h e  radiation of orally administered QIY is sufficiently penetrating 
t o  damage the intestinal t ract  which dominates the clinical picture. The  
LD60 for rats  is 17 pc/g according t o  Sullivan et al. (149) and the mean sur- 
vival time 8 days. Severe pathological changes were confined to the cecum 
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and the colon owing to longer retention of intestinal contents in these parts of 
the digestive tract. The radiation doses after ingestion of the LD60 are 1150 
rads to the small intestine. 2800 rads to the ascending colon, and 4700 rads to 
the descending colon; these doses are computed with the formula given by 
Thompson & HoIlis (153). Nold et al. (107) executed direct dose measure- 
ments by implantation of Schulman-Etzel dosimeters in various parts of the 
digestive tract in dogs and goats after administration of QOY.   he results 
agreed exceptionally well with the computed doses. I t  was estimated that  the 
maximum permissible dose of 300 mrads would be delivered by a dose of 4 
pc in dogs and 17 pc in goats. These values are reduced by diarrhea by a factor 
of 2 to 4, and increased in constipated animals by a factor of 3 to 7. By extrap- 
olation to man one obtains as maximum permissible intake 4 pc of which 
compares to 3.1 pc recommended by the National Bureau of Standards 
Handbook. 
Alkaline Earths.-The retention of 90Sr in the skeleton of rats determined 
over a period of 600 days can be represented by Rt=39 ex+ (-0.0106t) 
+0.23 e x p  (-0.0010Zt) [Moskalev (103)). The 9OSr concentration displays 
a considerably faster decrease owing to accretion of new bone. No differ- 
ences are found in the retention of several dosages of 90Sr varying between 
1 and 1000 pc per animal. This is contradicted by Ray & Lyon (123) who 
find a reduction in the mobilization of stable S r  administered prior to a 
single dose of 3 pc goSr/g, as well as  abolition of the protective effectiveness of 
a phosphorus-deficient diet. I t  may be concluded that  the presence of viable 
bone cells and an adequate blood circulation are necessary for the excretion of 
radiostrontium from the bone, and that  these factors will be impaired by 
high radiation doses. The retention of s5Sr by the skeleton of dogs (which 
follolvs a power law) shows a marked dependence on the age of the animals 
[Glad et al. (60)]: with increasing age the exponent d increases while the co- 
efficient c decreases. According to Parfenov (115), the skeletal concentration 
of gOSr in dogs can be represented by simple exponential functions; the half- 
time of the exponentials, however, is widely variable (between 665 and 2100 
days) for different bones. 
The question is yet to be resolved whether mobilization due to the osteo- 
clastic activity or an exchange process is responsible for the persistent but 
slow loss of alkaline earths from the skeleton. Rowland (127) attempted to 
find an answer from autoradiographic investigations after dogs had received 
226Ra by the multiple injection technique. He concludes tha t  an exchange 
process is probably the dominating mode of action on diffusely deposited 
226Ra as well as in hot spots. From a comparison of specific activities in bone 
and blood plasma, i t  is concluded that  there is no significant discrimination 
against ZZ6Ra in favor of Ca in transfer from blood to bone. 
Following incorporation of 9OSr in liver, spleen, and kidneys of rabbits a 
pronounced surplus of BOY was shown to exist ILloyd (93)J. This suggests 
translocation of the decay product formed in the body. Hence, dose calcula- 
tions for these parenchymatous organs, based on the assumption of radio- 
active equilibrium, will give an underestimation by a factor of a t  least 10. 
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Nevertheless, the skeleton accumulates considerably higher radiation doses, 
and, therefore, is still the critical Organ. 
Jee & Arnold (68) investigated the microlocaIization of gOSr and 226Ra in 
teeth in comparison to the radioactive actinides. They found distinct differ- 
ences, such as the penetration of the alkaline earths into the dentine while the 
actinides are concentrated on the surface. A characteristic of all bone-seeking 
radiometals is the spotty concentration in zones of active calcification. 
According to Bishop et al. (13), the total daily excretion rate of 85Sr in 
man after intravenous injection follows the equation Et = 16.5 exp (-0.41t) 
+4.7 exp (-0.16t)f 0.20 exp (-0.014t). The urinary excretion is strongly 
dominating during the first days; later urinary and fecal rates become nearly 
equal. For the assessment of body burdens as a function of the activity (U) 
excreted in the urine over 24 hours the following relation holds: R=0.06 
+0.65 U13. The validity of this formula was confirmed by Rundo & Williams 
(129) in a case of accidental inhalation exposure to 90SrC03 for which excre- 
tion and activity as  measured by a whole body Counter were determined. 
Systematic research on enrichment of in the human skeleton from fall-out 
has been continued by Kulp et al. (80). In the years 1958 and 1959 the aver- 
age content was 0.3 ppc per g Ca, and for adults was independent of age. For 
children one year of age, a mean value of 2.1 ppc per g. Ca was found. 
In three cases of 2Z6Ra-poisoning the microscopic distribution of a tracks 
in the long bones was found to depend upon the age a t  which the patient 
acquired the burden [Lloyd (92)]. In the patient who ingested 2?=Ra a t  the age 
of 17 most of the activity was found in the subperiosteal layer. The activity 
of the hot spots accounted for 12 per Cent of activity of the whole bone-sec- 
tion; in those patients who acquired 226Ra a t  32 and 47 years, the hot spots 
amounted to only 3 per Cent. The nonuniformity factor, defined as  the ratio 
of the highest concentration to the average concentration (assuming uniform 
distribution), varies in the range of 13 to 40. Supposing identical distribution 
of 90Sr, the nonuniformity factor could have a maximum value of six because 
of the longer range of the ß particles. The terminal dose rates delivered to the 
iacunae are computed as  5 to 18 rads per day using the formula of Spiers 
(142). 
The transfer of radiostrontium from mother to fetus was investigated 
with small rodents by Holmberg et al. (65) and Kriegel (75). A maximum 
transfer was found when the radionuclide was administered during the last 
days of gestation. Special mention may be made of the pronounced mobiliza- 
tion of from the bones of lactating rats [Kriegel & Neumann (76)l. QQSr is
discriminated against Ca by a factor of 12 on transfer from the mother's diet 
to the human fetus [Kulp et al. (80)l. 
A more detailed discussion of tlie numerous Papers which deal with 
physiological discrimination of alkaline earths and their basic meclianisms 
would exceed the scope of the present review. I t  may suffice to summarize 
briefly their main results. The 85Sr/226Ra ratio for dogs is 0.83 in bones, 0.8 in 
feces, and 1.83 in urine [Glad et al. (60)l. The tubular reabsorption of 226Ra in 
dogs compared to abSr and 45Ca decreases in the order: Ca, Sr, Ra;  whereas, 
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the iiltrafiltrable fraction of the plasma behaves in the opposite fashion 
[Hursh et al. (66)l. Essentially the Same results are obtained by Della Rosa 
et al. (43) in investigations on the renal excretion of 85Sr and 45Ca by dogs. 
The renal discrimination against 85Sr in man varies between 2.8 and 4.4 
[Barnes et al. (8), Bishop et al. (13)l. Garner et al. (58) compared the metabo- 
lism of 140Ba, S9Sr, and 45Ca in lactating cows and found marked difierences. 
The most important contribution in over-all discrimination in the Passage 
from diet to milk is the absorptive discrimination. The determination of sev- 
eral OR- and DF-values for cattle by Buldakov & Burov (18) yields no essen- 
tially new results or aspects above the earlier work of Comar & Ilrasserman 
(41). Close agreement exists over the ORmilk-diet between lactating animals 
and man [Lough et al. (95)] .  The ORmi~k-~iei. of cows and goats is 0.12, and 
does not depend on the dietary Ca-level [Comar et al. (42)]. 
Investigations into the basic mechanisms of intestinal absorptive dis- 
crimination do not yet yield a clear-cut picture [Lengemann 8z Comar (84), 
Palmer Sr Thompson (114), Wasserman (166)l. Similar discrepancies are 
found in investigations of the Sr/Ca discrimination on transfer from blood to 
bone [Lengemann (82), Likins et al. (88, 89), Samachson & Lederer (131)]. In 
connection with Kornberg's criticism of the OR concept (74), work by 
Thompson & Palmer (154) deserves Special attention. They followed the 
build up of $@Sr and 45Ca in the Skeleton of rats during chronic ingestion of the 
radionuclides. Sr/Ca discrimination is found to decrease in magnitude as the 
dietary Ca-level increases. Furthermore the ORbone-diet depends upon time as 
the retention of '$Ca decreases when the Ca-supply is increased, while the 
rate of goSr-removal from the bone remains practically constant. A correla- 
tion of Sr/Ca discrimination with age and dietary Ca- and P-levels was 
found by Wasserman & Comar (167). Stover et al. (148) reported the failure 
of a dog to discriminate between 90Sr and Ca given orally. 
The absorption of 90Sr from the digestive tract is enhanced by whole- 
body X-irradiation with doses of 200 r and higher [Lengemann (83)]. This 
effect is more pronounced for young rats than for mature animals. The intlu- 
ence of the irradiation could be due to an increased permeability as  weil as  a 
slower rate of transit through the irradiated intestinal tract [Lengemann & 
Comar (85)]. After local irradiation of an extremity with 2000 r an inhibition 
of accretion and an increase of the exchangeable fraction of bone is observed 
[Cohn (39)J. 
Some work has been devoted to functional or morphological disturbances 
in goSr-poisoned animals. That  these symptoms are pathogenically relevant, 
however, appears to be questionable. These changes are: enhanced urinary 
excretion of Dische positive compounds [Uspenskaya (159)], disturbances of 
DNA-metabolism of the liver [Uspenskaya (160)], glomerular-tubular dis- 
turbances of the kidneys [Poluboyarinova (118)], damage of the intestinal 
tract [Lebedev (SI)], alterations of the cardio-vascular functions [Korchem- 
kin (73)], and of conditioned reflex activity [Alekseyeva et al. (I), Klimova 
et 01. (71)]. Less well known is the fact that  a pronounced bone-seeker like 
radiostrontium may produce tumors in the soft tissue adjacent to bone. 
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Sissons & Vaughan (135) describe squamous carcinomas of the external 
auditory meatus following injection of newly-born rabbits with 0.5 pc 
90Sr/g. However, in rabbits injected with 0.2 to 1.0 pc/g a t  the age of one 
year no ear tumors are found. Impediment of bone growth was observed by 
Macpherson (96) on weanling rabbits following injection of 0.6 pc gOSr/g. 
Doses of 0.1 pc/g remained practically without effect, i.e., no significant 
stunting of growth is observed. I t  is difficult to decide whether direct radi- 
ation, or a general metabolic effect in the Course of radiation sickness, is the 
more important factor impairing bone growth. 
Finkel et al. (53) investigated the dependence of the S0Sr-toxicity on the 
administration pattern. CF1 mice received intraperitoneally a total of 0.25, 
0.5, or 1 pc/g, either as a single dose (S), or once a week for 5 weeks (FS), or 5 
times a week for 4 weeks (F20). Concerning the induction of osteosarcomas, 
S was decidedly more effective than F5 or F20. For the induction of lympho- 
mas, however, the influence of the dose rate obviously depends on the total 
dose given. The order of effectiveness after administration of I pc/g is 
S > F5 > F20, after 0.5 pc/g S = F5 > F20, and after 0.25 pcjg S <F5 = F20. 
These findings are not very amenable to interpretation. I t  may be concluded 
that  a t  least two processes are involved in the radiation induction of lym- 
phatic tumors. One process may be a direct response of the irradiated tissue, 
and the other an abscopal effect. The effectiveness of an initially high dose- 
rate, produced by a Single dose, is also confirmed for the induction of osteo- 
genic tumors from investigations on the consequences of continuous ingestion 
of 90Sr by CF1 mice [Finkel e l  al. (SI)]. These mice were fed with 10pc per g 
of dietary Ca from the day of conception onwards. Osteosarcomas appear 
much later and in smaller numbers than anticipated on the basis of experi- 
ence with single parenteral doses. I t  also turned out that  very young mice 
are not more sensitive to the carcinogenic effect of radiation. The true inci- 
dence of osteosarcomas may be quite different from its apparent incidence a t  
death, as has been already pointed out. In order to elucidate this question, 
Finkel et al. (52) investigated by use of serial roentgenographs the frequency 
of osteosarcomas following single parenteral doses of 9OSr (approximately 1 
pc/g) in CF1 and CBA mice. A differente in response between the two strains 
was observed which is not easily explicable: The average number of four 
tumors per mouse is about equal for both strains but the curve representing 
the cumulative incidence in CBA mice lags behind the CF1 curve by approxi- 
mately 60 days. The earliest roentgenographic diagnosis of an osteosarcoma 
was made in a CF1 mouse on the 98th day, in a CBA mouse on the 180th 
day. The tumor-rate (defined as the rate of appearance per 100 mouse-days) 
reaches a plateau, although the total energy absorbed is continuously in- 
creasing. Hence, i t  is concluded that the total accumulated radiation dose is 
less important than the radiation delivered during tlie first days. I t  is sug- 
gested tentatively that  a t  a rate of 150 rads per day irradiation for only one 
day is sufficient to give rise to the development of osteogenic neoplasms. Ob- 
viously these findings complicate the determination of the dose-effect reIa- 
tionship and the threshold dose. 
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Numerous investigations are devoted to the problem of removing intern- 
ally deposited radiostrontium from the body. T o  a certain extent, earlier 
findings have been confirmed, but also new conclusions and starting points 
have been reached. Carlquist & Nelson (21) find a reduction of the skeletal 
9oSr-deposition by stable Sr-compounds administered prior to or simultane- 
ously with 90Sr, while Ca-salts have a negative or no effect. This is in con- 
tradiction with Spencer et al. (140, 141) who observe markedly enhanced 
urinary excretion of sSSr after infusion or oral administration of Ca-gluconate 
to man. Seemingly the pseudoisotopic carrier-effect of Ca is confined to a 
very narrow dose region. This was observed earlier by Catsch & Melchinger 
(33) and would explain the discrepancy mentioned above. Also in disagree- 
ment with Spencer et al. (141), who found enhanced sSSr-excretion by man 
after oral administration of ammonium chloride, are investigations by Della 
Rosa et a2. (43). These authors could not observe an effect of ammonium 
chloride on dogs whereas an increased s5Sr-excretion took place after aliialo- 
sis bad been induced by sodium bicarbonate. Similarly, Walser et al. (165) 
found enhanced urinary excretion after intravenous infusion of sodium sul- 
fate. The mechanism by which sodium Sulfate promotes the intensified ex- 
cretion or s9Sr is not fully understood. Concerning the action of sodium or 
potassium rhodizonate, the positive results claimed by Lindenbaum (90) 
could not be reproduced by Dooronbekov et al. (44) nor by Volf (162). A 
chelating compound which is active, if only weakly, is BADE. I ts  effective- 
ness can be potentiated by combination with a different principle of action: 
isotopic dilution [Catsch (27, 28)]. The administration of the NazSr-chelate, 
instead of the ordinary Na2Ca-chelate or of the Na2-salt, results in a reduc- 
tion of skeletal deposition of 85Sr to about one half. This should be one of the 
strongest effects which have been achieved with early treatment. The 
amount of &5Sr which can be mobilized by delayed treatment with Na&- 
BADE is practically zero. In the same way the increased effectiveness of 
CaNa-citrate over that  of the Na-compound can be understood [Ogawa 
et al. (log)]. For fundamental reasons, i t  appears unlikely that  a major suc- 
cess in removal of radiostrontium already fixed in the bone can be achieved 
solely by application of chelators. Therefore, the observations of Knizhnikov 
(72) deserve close attention and should be confirmed as soon as possible: 
Namely, the chronic feeding of nontoxic amounts of sodium fluoride to mice 
and dogs results not only in a reduced deposition of 9OSr but  also in an 
accelerated elimination of 90Sr already deposited. Ogawa et al. (110) found en- 
hanced excretion of 90Sr from mice after administration of tetracycline. They 
attributed this action to the chelating properties of the compound. This ex- 
planation, however, appears to be questionable. According to Richards et al. 
(124) tetracycline does not seem to influence the initial deposition, but  to 
effect an accelerated mobilization from the bone. T o  what extent this is con- 
nected with the action of tetracycline on skeletal growth remains to be 
shown, as  does the question of effectiveness with other animal species. The 
attempt to increase the transfer-rate of radiostrontium from the blood into 
intestine, and to block its intestinal reabsorption by oral administration of 
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barium Sulfate or other agents, has yielded only a weak and hardly satis- 
factory effect [Volf (163, 164)]. The acceleration of Sr-elimination from bone 
by a phosphorus-deficient diet has been known for some time. I t  was as- 
sumed, however, that  such diets are only poorly tolerated and lead to 
marked histological changes of the Skeleton. Van Putten (161) demonstrated, 
however, that  effective phosphorus-deficient diets were tolerated relatively 
well and lead to a convincing reduction of the radiotoxicity of $OSr in mice. In 
this connection an observation by Uchiyama & Ukita (158) should be men- 
tioned: a Single oral dose of aluminium citrate promoted a markedly intensi- 
fied excretion of 90Sr injected parenterally into mice. This is explained by 
precipitation of phosphorus in the intestinal tract. 
The retention of inhaled '%Ir aerosol in rats was studied by Casarett et al. 
(23). The major fraction of the aerosol, with a mean particle size of 0.7 p, 
was retained by the upper parts of the respiratory tract. This is in contradic- 
tion to results with other radiometals. There is no readily apparent explana- 
tion for this discrepancy. The lg21r load of the upper parts of the respiratory 
tract is rapidly removed via the gastrointestinal tract. For this reason, 
together with the low absorption of lg21r, the digestive tract is the critical 
Organ. 
By autoradiographic studies Nelson et al. (105) observed very pronounced 
and rapid appearance of 13'Cs in the cartilage. Although the myocardium 
accumulates '37Cs to the Same extent as the skeletal muscle, i t  does not re- 
tain '37Cs for longer periods of time as does the skeletal muscle. Wasserman & 
Comar (168) investigated the influence of dietary K-levels on the retention of 
chronically ingested '3lCs in rats. The maximum effect observed was a two- 
fold reduction of '3'Cs-retention in response to a ninefold elevation of dietary 
K-concentration. Ac has been emphasized above, the OR in the case of the 
element pair Cs-K is not of major importance. This can be Seen from the 
variation of the OR„„i,di,t between 1 and 5.3, depending on the K-content 
of the diet. A sizable placental transfer of 13'Cs was to be expected and could 
experimentally be shown to take place in small rodents, especially during the 
last days of gestation [Kriegel et al. (78)l. A significant enhancement of 
'37Cs-excretion is effected by NaHCOa, NaZSOk, NaZHPO, and NaH2POt 
[Ogawa et al. (113)], the active mechanism has yet to be elucidated. OraI ad- 
ministration of a carbonic anhydrase inhibitor (diamox) for long periods of 
time reduces the body content of '3"s by about 20 per Cent [Richmond & 
Furchner (125)l. Following an accidental ingestion of 4 mc 13Ts by a techni- 
cian, only unspecific and slight impairment of health was observed [Fateyeva 
et al. (47)l. 
The intestinal absorption of "'"In is about 0.5 per Cent in rats. Following 
different routes of administration of the radiometal, the highest concentra- 
tions were found in the kidneys, Spleen, liver and salivary glands. A bioassay 
method is presented ~vhich allows an estimate of the body burden to be made 
from urinary excretion data [Smith et al. (137)l. 
2 62 CATSCH 
The enteral abSorption of  RU depends on its chemical form; in rabbits i t  
amounts to 10 to 15 per Cent for nitrosyl derivates, and approximately 3 per 
cent for the Chloride and the dioxide. However, the subsequent distribution 
of the absorbed fraction was identical for all compounds, the kidneys show- 
ing the highest concentrations [Bruce & Carr (15)l. The half-time of retained 
Io6Ru, administered as nitrosyl-trinitrate, is 1.6 days for the first 10 days and 
increases to 7 weeks thereafter. The retention of the serial doses in the case 
of a chronic oral exposure is somewhat less than after a single dose [Bruce & 
Carr (16)l. After inhalation of an 10GRu02 aerosol with a mean particle size of 
0.33 p, about 24 per ceilt of the particles is deposited in the lungs of mice. The 
retention of the fraction deposited is represented by Rt =83 exp (-O.lt)+15 
exp (-0.024t)+2 exp (-0.003t). This means that  essentially the Same con- 
ditions prevail as those following inhalation of a 5 3 9 P ~ 0 2  aerosol. I t  is note- 
worthy that relatively higher concentrations are observed in ovaries and ad- 
r e n a l ~  compared to the lungs. Assuming the lungs as  the critical Organ, a 
MPC of 1.3. 10-8pc/cc air is obtained from the values given above [Bair et al. 
(S)]. This compares with 6 .  10-gpc/cc which is the value recommended by the 
ICRP. From investigations of the pathological sequelae of lo6Ru inhalation, 
no consistent picture can yet be derived [Temple et al. (151)l. Administra- 
tion of EDTA or condensed phosphates proved to be ineffective in mobilizing 
internally deposited lO6Ru [Spode & Gensicke (143)l. 
The influence of various compounds on the retention and excretion of 
96Zr in mice and rats was tested by Ogawa et al. (111, 112). CaNa-citrate, 
EDTA, tetracycline, and small doses of stable carrier promoted a slight en- 
hancement of the urinary excretion. 
Although 'SZn, produced by the addition reaction of neutrons with 64Zn, is 
not a fission product, i t  is of rnajor practical importance as  a biospheric con- 
tarninant. Its presence in cyclotron workers is caused by the absorption of 
deuterons in 6 3 C ~  contained in the cyclotron. Ballou & Thompson (7) studied 
in detail the validity of MPC values given by the ICRP for this radionuclide. 
The retention of 65Zn injected intravenously into rats is found to be represent- 
able by a sum of three exponential terms. The highest concentrations of 
esZn were found in hair, bone and prostate of the rats. 10 to 20 per Cent of the 
nuclide is found to be absorbed from the digestive tract. After chronic feed- 
ing of 65Zn, steady state concentrations were observed long before the end of 
the feeding period. The agreement between the build-up values observed and 
those predicted is fairly good. The h lPC values calculated for water from 
single and chronic administration data are also in satisfactory agreement with 
each other. These values, however, are higher for most Organs than those 
given by the ICRP recommendations. Special attention should be devoted to 
very young organisms in view of the enhanced intestinal absorption and the 
relatively high placental transfer of 65211. Significant changes of uptake and 
distribution of orally administereduzn in mice were found after whole body 
X-irradiation [Matsui et al. (97)l. 
Despite its wide distribution, has received only little attention in the 
past. Recently, a considerable nurnber of Papers by Soviet authors (86) have 
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been devoted to its behavior and toxicity. Investigations with rats and 
rabbits indicate a variation in enteral absorption of between 13 and 33 per 
cent. Concentration in liver and kidneys is found to exceed that in all other 
Organs. Excretion is preferably urinary. The steady state concentration fol- 
lowing chronic feeding is reached relatively rapidly (approximately after 
0.5-2 months). The experimentally found dependence of the equilibrium 
concentration on concentration level of the diet is regarded as a carrier 
effect, the preparation being used having a relatively low specific activity. 
The steady state retention R, of 60Co obeys the relation R, =6.25a0.5 where 
a is the amount of activity given per day. In investigations concerned with 
radiotoxicity, rabbits received oral dosages of 1.25 and 12.5 pc/kg. These are 
quantities 100 and 1000 times, respectively, higher than those for water con- 
tained in the ICRP recommendations. Most prominent in the clinical picture 
are disturbances of erythropoesis and lymphopoesis. Especially follo\ving the 
higher dosage, a marked hyporegenerative anemia and a constant absolute 
lymphopenia develop. Disturbances in the case of the lower dosage are only 
observable when a functional Stress is applied. The radiation doses are 
computed as 0.1 and 0.61 rep per day, respectively, for ß irradiation of the 
liver, and 0.24 and 1.15 r per day, respectively, for y irradiation of the whole 
body. 
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